Form 4: Blueprint Medicines Executive Sells Shares to Cover Tax Obligations

Debra Durso-Bumpus, Chief People Officer of Blueprint Medicines, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 5, 2025, Debra Durso-Bumpus, Chief People Officer of Blueprint Medicines Corp, sold 5,157 shares of common stock at a price of $88.8 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Durso-Bumpus directly owns 49,606 shares of Blueprint Medicines Corp.
• The sale was not a discretionary trade but an automatic 'sell to cover' transaction to satisfy tax obligations.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes) and doesn't indicate any significant positive or negative sentiment.

Management Comments

• The sale occurred automatically to satisfy the tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment or misalignment of interests between management and shareholders.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine sale to cover tax obligations.

Key Dates